Table 2. Sites of First Recurrence and Median Overall Survival From Surgery and Median Survival After Diagnosis of Recurrence by Site.
| Site of Recurrence | No. | Median (95% CI) | ||
|---|---|---|---|---|
| Recurrence-Free Survival, mo | Survival After Recurrence, mo | Overall Survival, mo | ||
| Local only | 238 | 13.57 (12.61-14.06) | 9.36 (8.08-10.48) | 24.83 (22.96-27.863) |
| Local and distant recurrence | 48 | 11.99 (10.28-15.83) | 8.11 (5.22-11.79) | 23.82 (17.48-28.32) |
| Distant only | 193 | 11.14 (10.05-12.32) | 9.23 (7.82-11.43) | 20.61 (18.12-23.80) |
| Patients with any distant recurrence | 241 | 11.27 (10.38-12.55) | 8.94 (7.82-11.17) | 23.06 (20.43-25.36) |
| Oligometastatic | ||||
| Bone | 6 | NA | NE | NE |
| Distant nodal | 16 | 10.61 (7.85-15.14) | 13.17 (4.86-NE) | 25.36 (14.36-NE) |
| Liver | 99 | 9.66 (8.11-11.14) | 8.54 (7.03-9.62) | 20.43 (16.59-23.85) |
| Lung | 52 | 15.31 (11.76-20.00) | 15.04 (12.25-23.65) | 33.47 (24.77-48.72) |
| Other intra-abdominal | 26 | 14.06 (9.62-19.32) | 11.17 (5.85-13.40) | 29.11 (20.79-49.28) |
| Ovarian | 2 | NE | NE | NE |
| Polymetastatic | ||||
| Distant nodal and bone | 1 | NE | NE | NE |
| Liver and bone | 1 | NE | NE | NE |
| Liver and lung | 18 | 10.61 (8.97-12.94) | 4.53 (2.13-6.41) | 14.91 (11.83-20.99) |
| Liver, lung, and bone | 1 | NE | NE | NE |
| Liver, lung, and nodal | 2 | NE | NE | NE |
| Liver and nodal | 2 | NE | NE | NE |
| Liver and peritoneal | 1 | NE | NE | NE |
| Lung and nodal | 7 | NE | NE | NE |
| Lung and peritoneal | 7 | NE | NE | NE |
Abbreviation: NE, not estimable.